136 related articles for article (PubMed ID: 34039294)
1. Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center.
Eastman BM; Hippe DS; Wootton LS; Nyflot MJ; Thompson MJ; Pollack SM; Kim E; Spraker MB
BMC Cancer; 2021 May; 21(1):620. PubMed ID: 34039294
[TBL] [Abstract][Full Text] [Related]
2. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.
Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042
[TBL] [Abstract][Full Text] [Related]
3. Trends in practice patterns and outcomes: A decade of sarcoma care in the United States.
Song Y; Ecker BL; Tang R; Maggino L; Roses RE; DeMatteo RP; Fraker DL; Karakousis GC
Surg Oncol; 2019 Jun; 29():168-177. PubMed ID: 31196484
[TBL] [Abstract][Full Text] [Related]
4. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
5. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
Basile G; Mattei JC; Alshaygy I; Griffin AM; Catton CN; Chung PW; Shultz DB; Razak ARA; Demicco EG; Ferguson PC; Wunder JS
Cancer; 2020 Dec; 126(23):5098-5108. PubMed ID: 32910462
[TBL] [Abstract][Full Text] [Related]
6. Time to treatment initiation and survival in adult localized, high-grade soft tissue sarcoma.
Featherall J; Curtis GL; Lawrenz JM; Jin Y; George J; Scott J; Shah C; Shepard D; Rubin BP; Nystrom LM; Mesko NW
J Surg Oncol; 2019 Dec; 120(7):1241-1251. PubMed ID: 31587292
[TBL] [Abstract][Full Text] [Related]
7. Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.
Gannon NP; Stemm MH; King DM; Bedi M
J Cancer Res Clin Oncol; 2019 May; 145(5):1321-1330. PubMed ID: 30847552
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
Movva S; von Mehren M; Ross EA; Handorf E
J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766
[TBL] [Abstract][Full Text] [Related]
10. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
[TBL] [Abstract][Full Text] [Related]
12. Modern Management of High-risk Soft Tissue Sarcoma With Neoadjuvant Chemoradiation: A Single-center Experience.
Byun DJ; Katz LM; Xiao J; Rapp TB; Paoluzzi L; Rosen G; Schiff PB
Am J Clin Oncol; 2021 Jan; 44(1):24-31. PubMed ID: 33086232
[TBL] [Abstract][Full Text] [Related]
13. High grade soft tissue sarcoma of the flexor fossae. Size rather than compartmental status determine prognosis.
Yang RS; Lane JM; Eilber FR; Dorey FJ; al-Shaikh R; Schumacher LY; Rosen G; Forscher CA; Eckardt JJ
Cancer; 1995 Oct; 76(8):1398-405. PubMed ID: 8620414
[TBL] [Abstract][Full Text] [Related]
14. Socio-economic factors affect the outcome of soft tissue sarcoma: an analysis of SEER data.
Cheung MR; Kang J; Ouyang D; Yeung V
Asian Pac J Cancer Prev; 2014; 15(1):25-8. PubMed ID: 24528034
[TBL] [Abstract][Full Text] [Related]
15. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.
Yoneda Y; Kunisada T; Naka N; Nishida Y; Kawai A; Morii T; Takeda K; Hasei J; Yamakawa Y; Ozaki T;
Eur J Surg Oncol; 2014 Jan; 40(1):49-54. PubMed ID: 24075825
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative Electron Radiation Therapy Combined with External Beam Radiation Therapy after Gross Total Resection in Extremity Soft Tissue Sarcoma: A European Pooled Analysis.
Roeder F; de Paoli A; Saleh-Ebrahimi L; Alldinger I; Bertola G; Boz G; Navarria F; Cuervo M; Uhl M; Alvarez A; Buechler M; Lehner B; Debus J; Calvo FA; Krempien R
Ann Surg Oncol; 2018 Dec; 25(13):3833-3842. PubMed ID: 30276647
[TBL] [Abstract][Full Text] [Related]
18. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
19. Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection.
Jakob J; Tunn PU; Hayes AJ; Pilz LR; Nowak K; Hohenberger P
J Surg Oncol; 2014 Jun; 109(8):786-90. PubMed ID: 24619722
[TBL] [Abstract][Full Text] [Related]
20. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
Schaefer IM; Hornick JL; Barysauskas CM; Raut CP; Patel SA; Royce TJ; Fletcher CDM; Baldini EH
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):375-383. PubMed ID: 28463157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
